1. Home
  2. SRRK vs CAMT Comparison

SRRK vs CAMT Comparison

Compare SRRK & CAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

N/A

Current Price

$56.23

Market Cap

6.8B

Sector

Health Care

ML Signal

N/A

Logo Camtek Ltd.

CAMT

Camtek Ltd.

HOLD

Current Price

$146.61

Market Cap

7.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRRK
CAMT
Founded
2012
1987
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Electronic Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
7.4B
IPO Year
2018
2000

Fundamental Metrics

Financial Performance
Metric
SRRK
CAMT
Price
$56.23
$146.61
Analyst Decision
Strong Buy
Buy
Analyst Count
13
11
Target Price
$56.17
$158.55
AVG Volume (30 Days)
981.1K
453.6K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$14.61
Revenue Next Year
$534.24
$19.36
P/E Ratio
N/A
$155.63
Revenue Growth
N/A
N/A
52 Week Low
$27.07
$75.75
52 Week High
$58.49
$215.99

Technical Indicators

Market Signals
Indicator
SRRK
CAMT
Relative Strength Index (RSI) 62.50 45.62
Support Level $45.81 $146.00
Resistance Level $58.49 $158.46
Average True Range (ATR) 2.38 9.34
MACD 0.63 -0.61
Stochastic Oscillator 93.21 16.92

Price Performance

Historical Comparison
SRRK
CAMT

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About CAMT Camtek Ltd.

Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry. Its systems inspect wafers for various semiconductor market segments, including Advanced Packaging, Chiplets, HBM, Compound Semiconductors, Memory, CMOS Image Sensors, Power, RF and MEMS, serving the industry's IDMs, OSATs, and foundries. Geographically, it derives maximum revenue from China followed by Asia Pacific, Korea, United States, and Europe. The company's products and services include Surface Inspection, Bump Inspection and Metrology, and others.

Share on Social Networks: